NVS

Novartis AG - ADR

Halal Rating :
Comfortable
Last Price $97.59 Last updated:
Market Cap $199.35b
7D Change -1.69%
1 Year Change -10.03%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 29, 2024

Novartis AG is a global pharmaceutical company headquartered in Basel, Switzerland. The company develops, manufactures, and markets branded and generic prescription and over-the-counter drugs. Their portfolio includes innovative medicines, generics, and biosimilars.

Novartis focuses on several therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and ophthalmology. The company invests heavily in research and development to create new treatments for various medical conditions.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
June 30, 2024 $12.51b $8.83b - $246.0m 0.00% 2.79%
March 31, 2024 $11.83b $8.42b $6.0m $221.0m 0.05% 2.62%
Dec. 31, 2023 $11.78b $9.41b - $217.0m 0.00% 2.31%

Company Impact

Help us evaluate Novartis AG - ADR's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates